MedTrace Logo

Smoking Reduction or Cessation With Nicotine Replacement Therapy

NCT00840242 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2012-04-25

No results posted yet for this study

Summary

The purpose of this study is to test the success rate of smoking reduction or cessation with different nicotine products.

Conditions

  • Smoking Cessation

Interventions

DRUG

Nicotine gum

8-12 pieces per day, maximum 24 daily

DRUG

Placebo gum

8-12 pieces per day, maximum 24 daily

DRUG

Nicotine inhaler

6-12 cartridges per day, maximum 12 daily

DRUG

Placebo inhaler

6-12 cartridges per day, maximum 12 daily

Sponsors & Collaborators

  • McNeil AB

    lead INDUSTRY

Principal Investigators

  • Elisabeth Kruse, PhD · McNeil AB

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-02-28
Primary Completion
2000-05-31
Completion
2000-05-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00840242 on ClinicalTrials.gov